World Library  
Flag as Inappropriate
Email this Article

Androgenetic alopecia

Article Id: WHEBN0013925445
Reproduction Date:

Title: Androgenetic alopecia  
Author: World Heritage Encyclopedia
Language: English
Subject: Aga, Toupée, Noncicatricial alopecia
Collection:
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Androgenetic alopecia

Androgenic alopecia
Classification and external resources
10 DiseasesDB MedlinePlus eMedicine MeSH D000505

Androgenic alopecia (also known as androgenetic alopecia, alopecia androgenetica, male pattern baldness) is hair loss that occurs due to an underlying susceptibility of hair follicles to androgenic miniaturization. It is the most common cause of hair loss and will affect up to 70% of men and 40% of women at some point in their lifetime. Men typically present with hairline recession at the temples and vertex balding while women normally diffusely thin over the top of their scalps.[1][2][3] Both genetic and environmental factors play a role, and many etiologies remain unknown.

Classic androgenic hair loss in males begins above the temples and vertex, or calvaria, of the scalp. As it progresses, a rim of hair at the sides and rear of the head remains. This has been referred to as a 'Hippocratic wreath', and rarely progresses to complete baldness.[4] The Hamilton-Norwood scale has been developed to grade androgenic alopecia in males.

Female androgenic alopecia has been colloquially referred to as 'female pattern baldness', although its characteristics can occur in males as well. It more often causes diffuse thinning without hairline recession, and like its male counterpart rarely leads to total hair loss.[5] The Ludwig scale grades severity of androgenic alopecia in females.

Animal models of androgenic alopecia occur naturally and have been developed in transgenic mice,[6] chimpanzees (Pan troglodytes), bald uakaris (Cacajao rubicundus) and stump-tailed macaques (Macaca speciosa and Macaca arctoides), of which the macaques demonstrate the greatest incidence and most prominent hair loss.[7][8]

Causes

Hormonal etiology

Research indicates that the initial programming of pilosebaceous units begins in utero.[9] The physiology is primarily androgenic, with dihydrotestosterone (DHT) the major contributor at the dermal papillae.  Below normal values of Sex hormone-binding globulin (SHBG), Follicle-stimulating hormone (FSH), testosterone and epitestosterone are present in men with premature androgenic alopecia compared to normal controls.[10] Although follicles were previously thought permanently gone in areas of complete hair loss, they are more likely dormant, as recent studies have shown the scalp contains the stem cell progenitors from which the follicles arose.[11]

Transgenic studies have shown that growth and dormancy of hair follicles are related to the activity of Insulin-like growth factor (IGF) at the dermal papillae, which is affected by DHT.[12] Androgens are important in male sexual development around birth and at puberty. They regulate sebaceous glands, apocrine hair growth and libido. With increasing age,[13] androgens stimulate hair growth on the face, but suppress it at the temples and scalp vertex, a condition that has been referred to as the 'androgen paradox'.[14]

These observations have led to study at the level of the mesenchymal dermal papillae.[15][16] Type 1 and 2 5α reductase enzymes are present at pilosebaceous units in papillae of individual hair follicles.[17] They catalyze formation of the androgens testosterone and DHT, which in turn regulate hair growth.[14] Androgens have different effects at different follicles: they stimulate IGF-1 at facial hair, leading to growth, but stimulate TGF β1, TGF β2, dickkopf1 and IL-6 at the scalp, leading to catagenic miniaturization.[14] Hair follicles in anaphase express four different caspases. Tumor necrosis factor inhibits elongation of hair follicles in vitro with abnormal morphology and cell death in the bulb matrix.[18]

Studies look at serum levels of IGF-1 show it to be increased with vertex balding.[19][20] Earlier work looking at in vitro administration of IGF had no effect on hair follicles when insulin was present, but when absent, caused follicle growth. The effects on hair of IGF-I were found greater than IGF-II.[21] Later work also showed IGF-1 signalling controls the hair growth cycle and differentiation of hair shafts,[12] possibly having an anti-apoptotic effect during the catagen phase.[22] In situ hybridization in adult human skin have shown morphogenic and mitogenic actions of IGF-1.[23] Mutations of the gene encoding IGF-1 result in shortened and morphologically bizarre hair growth and alopecia.[24] IGF-1 is modulated by IGF binding protein, which is produced in the dermal papilla.[25]

DHT inhibits IGF-1 at the dermal papillae.[26] Extracellular histones inhibit hair shaft elongation and promote regression of hair follicles by decreasing IGF and alkaline phosphatase in transgenic mice.[27] Silencing P-cadherin, a hair follicle protein at adherens junctions, decreases IGF-1, and increases TGF beta 2, although neutralizing TGF decreased catagenesis caused by loss of cadherin, suggesting additional molecular targets for therapy. P-cadherin mutants have short, sparse hair.[28]

At the occipital scalp, androgens enhance inducible nitric oxide synthase (iNOS), which catalyzes production of nitric oxide from L-arginine.[14] The induction of nitric oxide synthase usually occurs in an oxidative environment, where high levels of nitric oxide produced interact with superoxide, leading to peroxynitrite formation and cell toxicity. iNOS has been suggested to play a role in host immunity by participating in anti-microbial and anti-tumor activities as part of the oxidative burst[29] of macrophages.[30] The gene coding for nitric oxide synthase is on human chromosome 17.[31]

There is also crosstalk between androgens and the Wnt-Beta-catenin signaling pathway that leads to hair loss. At the level of the somatic stem cell, androgens promote differentiation of facial hair dermal papillae, but inhibit it at the scalp.[14] Other research suggests the enzyme prostaglandin D2 synthase and its product prostaglandin D2 (PGD2) in hair follicles as contributive.[32]

Men with androgenic alopecia typically have higher 5-alpha-reductase, lower total testosterone, higher unbound/free testosterone and higher free androgens, including DHT.[10][33] 5-alpha-reductase converts free testosterone into DHT, and is highest in the scalp and prostate. DHT is most commonly formed at the tissue level by 5α-reduction of testosterone.[34] The genetic corollary that codes for this enzyme has been discovered.[35]

Prolactin has also been suggested to have different effects on the hair follicle across gender.[36] It seasonally modulates[37] and can delay[38] hair growth in animal models. In vitro models show it inhibits hair follicle growth.[39] In vivo it can inhibit facial hair growth in humans.[40] Researchers have suggested it works through paracrine action.[41]

Genetics

Balding is multifactorial, with several lines of evidence suggesting that it most likely functions by a diathesis–stress model.  Since androgens and androgen receptors (AR) are the initiating cause of androgenic alopecia, their genetic corollaries are a subject of much research. Some involved genes are X-linked, with men whose fathers show hair loss 2.5 times more likely to experience it themselves regardless of maternal report.[42] The maternal line is crucial as well, however, as it contains the androgen receptor gene, which provides the necessary diathesis for androgenic alopecia.[43]
The specific variant of the AR for baldness is on a recessive allele, so a woman would need two X chromosomes with the defect to show male pattern hair loss.[44] The EDA2R gene on the X chromosome at Xq11-q12, close to the area which codes for the androgen receptor gene, has been suggested by some researchers as specific to androgenic alopecia.[45] An allele on chromosome 3 at 3q26 also contributes.[46]

Genetic causes of hair texture and non-androgenic hair loss have been discovered as well. One is P2RY5, mutations of which affect hair structure and woolly hair.[47] Variants at this site can lead to baldness.[48] Other research identified the gene SOX21, Y-linked, as related to certain non-androgenic alopecias.[49]

Much research has gone into the genetic component of male pattern baldness, or androgenetic alopecia (AGA). Research indicates that susceptibility to premature male pattern baldness is largely the cause of sex-influenced inheritance (because males can pass on the trait to their sons which would be impossible if it were x-linked). Other genes that are not sex linked are also involved.

Researchers from the University of Bonn in Germany indicate the androgen receptor gene as the cardinal prerequisite for balding.[43] They conclude that a certain variant of the androgen receptor is needed for AGA to develop. In the same year the results of this study were confirmed by other researchers.[44] This gene is recessive and a female would need two X chromosomes with the defect to show typical male pattern alopecia. Seeing that androgens and their interaction with the androgen receptor are the cause of AGA it seems logical that the androgen receptor gene plays an important part in its development.

Other research in 2007 suggests another gene on the X chromosome, that lies close to the androgen receptor gene, is an important gene in male pattern baldness. They found the region Xq11-q12 on the X-chromosome to be strongly associated with AGA in males. They point at the EDA2R gene as the gene that is mostly associated with AGA. This finding has been replicated in at least three following independent studies.

Other genes involved with hair loss have been found, including a gene located at 3q26.[46] This gene is also involved in a type of baldness associated with mental retardation. This gene is recessive.

Another gene that might be involved in hair loss is the P2RY5. This gene is linked to hair structure. Certain variants can lead to baldness at birth while another variant causes "wooly hair".[50]

Recent research confirmed the X-linked androgen receptor as the most important gene, with a gene on chromosome 20 being the second most important determinant gene (snpedia). This research suggests that heredity of AGA is X-linked; however, research has also shown that a person with a balding father has a significantly greater chance of experiencing hair loss. Men whose fathers had experienced hair loss were 2.5 times more likely to experience hair loss themselves, regardless of the mother's side of the family, which may suggest Y-linked heredity plays a role.[51][52]

Most studies support a greater paternal inheritance over maternal grandfather inheritance including in 740 Taiwanese subjects,[53] 421 Korean subjects,[54] 998 Korean subjects[55] and in the Ohio study, 254 subjects, 1.9 times for the father vs the maternal grandfather (1.6 times), although the mother herself having alopecia raised the risk 10fold.[51] (Mother>Father>Maternal grandfather>Paternal grandfather>Maternal Grandmother>Paternal grandmother, although only father's hair loss retained significant when all family history was taken together in a multiple logistic regression - this may be due to the low sample size) Since the AR receptor is only inherited from the X chromosome and X chromosome can only come from the mother (Y must come from the father), there are likely genes other than the AR receptor that come into play.

Age


Androgens stimulate growth of facial hair, but can suppress scalp hair, a condition which has been called the 'androgen paradox'.[14] The American Academy of Dermatology reports that in adult men, the incidence of androgenic alopecia is roughly equivalent to chronological age, with half of men experiencing hair loss by age 50.[56]

A number of hormonal changes occur with aging:

  1. Decrease in testosterone
  2. Decrease in serum DHT and 5-alpha reductase
  3. Decrease 3AAG, a peripheral marker of DHT metabolism,
  4. Increase in SHBG.
  5. Decrease in a)androgen receptors, b)5-alpha reductase type I and II activity and c)aromatase in the scalp with age.[57][58]

This decrease in androgens, androgen receptors and the increase in SHBG are opposite the increase in androgenic alopecia with aging. This is not intuitive, as testosterone and its peripheral metabolite, DHT, accelerate hair loss, and SHBG is thought to be protective. The ratio of T/SHBG, DHT/SHBG decreases by as much as 80% by age 80, in numeric parallel to hair loss, and approximates the pharmacology of anti-androgens such as finasteride.[56]

Free testosterone decreases in men by age 80 to levels double that of a woman at age 20. 30% of normal male testosterone level, the approximate level in females, is not enough to induce alopecia; 60%, closer to the amount found in elderly men, is sufficient.[59] It has been theorized that the testicular secretion of testosterone "sets the stage" for androgenic alopecia as a multifactorial diathesis stress model, related to hormonal predisposition, environment and age. Supplementing eunuchs with testosterone during their 2nd decade, for example, causes slow progression of androgenic alopecia over many years, while testosterone late in life causes rapid hair loss within a month.[60]

An example of premature age effect is Werner's syndrome, a condition of accelerated aging from low fidelity copying of mRNA. Affected children display premature androgenic alopecia.[61]

Metabolic syndrome


Multiple cross sectional studies have found association between early androgenic alopecia, insulin resistance and metabolic syndrome,[62][63] with low HDL being the component of metabolic syndrome with highest association.[64] Linolenic and linoleic acids, two major dietary sources of HDL, are 5 alpha reductase inhibitors.[65] It has been suggested that premature androgenic alopecia and insulin resistance are a clinical constellation that represents the male homologue, or phenotype, of polycystic ovary syndrome.[66] Others have found a higher rate of hyperinsulinemia in family members of women with polycystic ovarian syndrome.[67]

In support of the association, finasteride improves glucose metabolism and decreases glycosylated hemoglobin HbA1c, a surrogate marker for diabetes mellitus.[68] The low SHBG seen with premature androgenic alopecia is also associated with, and likely contributory to, insulin resistance,[69] and for which it still is used as an assay for pediatric diabetes mellitus.[70]

Obesity leads to upregulation of insulin production and decrease in SHBG. Further reinforcing the relationship, SHBG is downregulated by insulin in vitro, although SHBG levels do not appear to affect insulin production.[71] In vivo, insulin stimulates both testosterone production and SHBG inhibition in normal and obese men.[72] The relationship between SHBG and insulin resistance has been known for some time; decades prior, ratios of SHBG and adiponectin were used before glucose to predict insulin resistance.[73] Patients with Laron syndrome, with resultant deficient IGF, demonstrate varying degrees of alopecia and structural defects in hair follicles when examined microscopically.[24]

Because of its association with metabolic syndrome and altered glucose metabolism, both men and women with early androgenic hair loss should be screened for impaired glucose tolerance and diabetes mellitus II.[74] A low fat and high fiber diet combined with regular aerobic exercise increases SHBG and insulin sensitivity.[75] Regarding androgenic impact of diet with exercise, a study found increased protein intake led to higher concentrations of free and total testosterone immediately post exercise.[76]

Measurement of subcutaneous and visceral adipose stores by MRI, demonstrated inverse association between visceral adipose and testosterone/DHT, while subcutaneous adipose correlated negatively with SHBG and positively with estrogen. Subcutaneous fat did not correlate with androgens once the SHBG relationship was taken into account.[77] SHBG association with fasting blood glucose is most dependent on intrahepatic fat, which can be measured by MRI in and out of phase imaging sequences. Serum indices of hepatic function and surrogate markers for diabetes, previously used, show less correlation with SHBG by comparison.[78]

Female patients with mineralocorticoid resistance present with androgenic alopecia.[79]

IGF levels have been found lower in those with metabolic syndrome.[80] Circulating serum levels of insulin Growth Factor-1 (IGF-1) are increased with vertex balding, although this study did not look at mRNA expression at the follicle itself.[20] Locally, IGF is mitogenic at the dermal papillae and promotes elongation of hair follicles. The major site of production of IGF is the liver, although local mRNA expression at hair follicles correlates with increase in hair growth. IGF release is stimulated by GH (growth hormone). Methods of increasing IGF include exercise, hypoglycemia, low fatty acids, deep sleep (stage IV REM), estrogens, and consumption of amino acids like arginine and leucine. Obesity and hyperglycemia inhibit its release. IGF also circulates in the blood bound to a large protein whose production is also dependent on GH. GH release is dependent on normal thyroid hormone. During the sixth decade of life, GH decreases in production. Because growth hormone is pulsatile and peaks during sleep, serum IGF is used as an index of overall growth hormone secretion. The surge of androgens at puberty drives an accompanying surge in growth hormone.[81]

Evolutionary biology

Some studies have suggested a survival advantage with androgenic alopecia.[82] Psychologists have noted when showing subjects people with different appearances, decreased cranial hair was associated with social maturity, appeasement, decreased attractiveness and aggressiveness, and older age.[83]

A study from South Korea showed most people rated balding men less attractive. Men and women viewed six male models with different levels of facial and cranial hair, and participants rated each combination on 32 adjectives related to social perception. Males with facial hair and those with bald or receding hair were rated as being older than those who were clean shaven or had a full head of hair. Beards and full heads of hair were seen as more aggressive, while baldness was associated with social maturity.[81]

More theories include that baldness signaled dominance, social status, or longevity.[84] Biologists have hypothesized the larger sunlight exposed area would allow more vitamin D to be synthesized, which might have been a "finely tuned mechanism to prevent prostate cancer," as the malignancy itself is also associated with higher levels of DHT.[85][86] Other hypotheses include genetic linkage to beneficial traits unrelated to hair loss and genetic drift.

There is no consensus regarding the details of the evolution of male pattern baldness. The assertion that MPB is intended to convey a social message is supported by the fact that the distribution of androgen receptors in the scalp differs between men and women, and older men or women with high androgen levels often exhibit diffuse thinning of hair as opposed to male pattern baldness.

Male pattern baldness is mostly the result of a genetic event that causes dihydrotestosterone (DHT), a male hormone, to cause the hair follicles to atrophy. The hair produced is progressively smaller, until it is practically invisible (or may disappear completely).

In a study by Muscarella and Cunningham,[83] males and females viewed 6 male models with different levels of facial hair (beard and mustache or none) and cranial hair (full head of hair, receding and bald). Participants rated each combination on 32 adjectives related to social perceptions. Males with facial hair and those with bald or receding hair were rated as being older than those who were clean-shaven or had a full head of hair. Beards and a full head of hair were seen as being more aggressive and less socially mature, and baldness was associated with more social maturity.

Other evolutionary hypotheses include genetic linkage to beneficial traits unrelated to hair loss, and genetic drift.

Female androgenic alopecia

Female androgenic alopecia, clinically known as 'female pattern hair loss,' (FPHL) more often causes diffuse thinning without hairline recession. Approximately 30% of caucasian adult females experience hair loss.[87] Like its male counterpart, the condition rarely leads to total hair loss, although it is possible.[87] Treatment options to arrest progression and stimulate regrowth include finasteride, the androgen-independent growth promoter minoxidil, or androgen receptor antagonists spironolactone and cyproterone acetate. These work best initiated early, and hair transplantation can be considered in more advanced cases.[87]

A recently published study comparing monozygotic female twins found a number of factors associated with hair loss in women with varying degrees of statistical certainty, and stratified by pattern. Factors associated with increased temporal hair loss that were statistically significant (p < 0.05) were as follows:

  • more children (p = 0.005)
  • longer sleep duration (p = 0.006)
  • diabetes mellitus (p = 0.008)
  • lack of exercise (p = 0.012)
  • hypertension (p = 0.027)
  • divorce or separation (p = 0.034)
  • multiple marriages (p = 0.040)

Frontal hair loss, like temporal, included hypertension (p = 0.001) and longer sleep duration (p = 0.011) as risk factors, but also included PCOS (p = 0.002), lack of hat use (p = 0.017), smoking (p = 0.021), high income (p = 0.023), diabetes mellitus (p = 0.023), stress (p = 0.034), and multiple marriages (p = 0.043).

Statistically significant causes of vertex hair loss were: lack of sun protection (p = 0.020), less caffeine (p = 0.040), and a history of skin disease (p = 0.048). Higher testosterone levels were associated with increased temporal and vertex hair loss patterns (p < 0.039). Stress, smoking, more children, and a history of hypertension or cancer were associated with increased hair thinning (p < 0.05). It is unknown to what degree factors contributing to female hair loss overlap with those in men.[88] Later studies have found that prolactin is unrelated to female androgenic pattern hair loss, despite earlier in vitro studies suggesting that it inhibited growth.[89] Female patients with mineralocorticoid resistance present with androgenic alopecia.[79] Older studies have found a slight relationship of prolactin with female androgenic hair loss.[90]

Although baldness is not as common in women as in men, the psychological effects of hair loss tend to be much greater. Typically the frontal hairline is preserved but the density of hair is decreased on all areas of the scalp. Previously it was believed to be caused by testosterone just as in male baldness, but most women who lose hair have normal testosterone levels.[91]

However, female hair loss has become a growing problem which, according to the American Academy of Dermatology, affects around 30 million women in the United States. Although hair loss in females normally occurs after the age of 50 or even later when it does not follow events like pregnancy, chronic illness, crash diets, and stress among others, it is now occurring at earlier ages with reported cases in women as young as 15 or 16.[92]

Causes of female hair loss may vary from those that affect men. In the case of androgenic alopecia female hair loss occurs as a result of the action of androgens hormones (testosterone, androsteinedione, and dihydrotestosterone (DHT).[93] These male hormones normally occur in small amounts in women.

However, according to Ted Daly, MD, a dermatologist from Nassau University Medical Center on Long Island, androgenic alopecia is not the main cause of hair loss in women and dermatologists now prefer to call this condition female pattern hair loss (or Ludwig Pattern Baldness after the scale developed to diagnose it) instead of using the term androgenic alopecia. He adds that the female pattern is diffuse and goes around the whole top of the head and can affect women at any time.[94]

There are other instances in which the actions of hormones may also cause female hair loss. Some examples are: pregnancy, menopause, presence of ovarian cysts, birth control pills with a high androgen index, polycystic ovary syndrome. Also thyroid disorders, anemia, chronic illness and some medications can also cause female hair loss.[95]

In Animals

Baldness is not only a human trait.

One interesting case study is the maneless male Tsavo lion. The Tsavo lions prides are unique in that they frequently have only a single male lion with an average of 7 to 8 adult females, as opposed to 4 females in other lion species prides. It is theorized that Tsavo males may have heightened levels of testosterone, which could explain both their reputation for aggression and dominance, indicating that manelessness may at one time have had an alpha correlation.[96]

Effects

Psychological

Androgenic alopecia is typically experienced as a "moderately stressful condition that diminishes body image satisfaction".[97] However, although most men regard baldness as an unwanted and distressing experience, they usually are able to cope and retain integrity of personality.[98]

Diagnosis

The diagnosis of androgenic alopecia can be usually established based on clinical presentation in men. In women, the diagnosis usually requires more complex diagnostic evaluation. Further evaluation of the differential requires exclusion of other causes of hair loss, and assessing for the typical progressive hair loss pattern of androgenic alopecia.[99] Trichoscopy can be used for further evaluation.[100] Biopsy may be needed to exclude other causes of hair loss,[101] and histology would demonstrate perifollicular fibrosis.[102][103]

Management

Main article: Management of androgenic alopecia

Conventional medicine

Early stages of hair loss can be slowed or reversed with medication, with FDA approved drugs being minoxidil and finasteride.[104] Topical formulations of finasteride have similar efficacy to systemic, though prostate weight and serum PSA levels were not measured to exclude systemic absorption of topical application as the cause of hair growth.[105] Other treatment options include tretinoin combined with minoxidil, dutasteride, ketoconazole shampoo, and spironolactone.[106]

More advanced cases may be resistant or unresponsive to medical therapy, and require hair transplantation. Naturally-occurring units of one to four hairs, called follicular units, are excised and moved to areas of hair restoration. These follicular units are surgically implanted in the scalp in close proximity and in large numbers. The grafts are obtained from either Follicular Unit Transplantation (FUT) or Follicular Unit Extraction (FUE). In the former, a strip of skin with follicular units is extracted and dissected into individual follicular unit grafts. The surgeon then implants the grafts into small incisions, called recipient sites.[107][108] Specialized scalp tattoos can also mimic the appearance of a short buzzed haircut.[109][110]

Alternative and future therapies

The field of research to prevent and treat androgenic hair loss is vast, with systemic and topical therapies with varying degrees of efficacy. In the United States alone, it is a multi-billion dollar industry. Low-level laser therapy (LLLT) claims to stimulate hair growth through "photo-biostimulation" of hair follicles, but has limited evidence of benefit or safety.[111] Saw palmetto (Serenoa repens) in one small study demonstrated increased hair growth in 6/10 men with mild to moderate androgenetic alopecia,[112] and another study revealed that saw palmetto extract applied topically in a lotion and shampoo base led to a 35% increase in hair density, but these studies were very small and a proper larger clinical trial on androgenetic alopecia is needed.[113] The dietary supplement L-carnitine induces hair growth in vitro,[114] but it is not approved by the U.S. Food and Drug Administration (FDA).[115] Consumption of grateloupia elliptica, a red seaweed in Jeju Island, South Korea, has the potential to treat androgenic alopecia and alopecia areata.[116][117] Topical IGF in a liposomal vehicle thickens and elongates hair in transgenic mice with androgenic alopecia.[118] The enzyme prostaglandin D2 (PGD2) was present in the scalp of balding men at higher levels than those with hair, and prevented hair follicle maturation, with the possibility of treatment based on this research by 2014.[119][120][121][122]

Myths


There are many myths regarding the possible causes of baldness and its relationship with one's virility, intelligence, ethnicity, job, social class, wealth, etc. While skepticism is warranted due to lack of scientific validation, some of these myths may have a degree of underlying truth.

Research suggests that the gene for the androgen receptor, which is significant in determining probability for hair loss, is located on the X chromosome and so is always inherited from the mother's side for men.[123] There is a 50% chance that a person shares the same X chromosome as his maternal grandfather. Because women have two X chromosomes, they will have two copies of the androgen receptor gene while men only have one. However, research has also shown that a person with a balding father also has a significantly greater chance of experiencing hair loss. Men whose fathers had experienced hairloss were 2.5 times more likely to experience hairloss themselves, regardless of the mother's side of the family.[51][52]

Because it increases testosterone levels many internet forums have put forward the idea that weight training and other forms of exercise increase hair loss in pre-disposed individuals. Although scientific studies do support a correlation between exercise and testosterone, no direct study has found a link between exercise and baldness. However a few have found a relationship between a sedentary lifestyle and baldness suggesting that some exercise is beneficial. It is possible that the type or quantity of exercise may influence hair loss; more studies are needed.[124][125] Note that testosterone levels are not a good marker of baldness, and many studies actually show paradoxical low testosterone in balding persons, although research on the implications is limited.

This notion may have arisen because cholesterol is involved in the process of neurogenesis and is also the base material from which the body ultimately manufactures DHT. While the notion that bald men are more intelligent may lack credibility in the modern world, in the ancient world if a person was bald it was likely that he had an adequate amount of fat in his diet. Thus, his mental development was probably not stunted by malnutrition during his crucial formative years, he was more likely to be wealthy, and also to have had access to a formal education. However, a sedentary lifestyle is less likely to correlate with intelligence in the modern world, and dietary fat content is not linked to economic class in modern developed countries. Another possibility is that for some people, social standing accrued through intelligence can in mating compensate for physical attractiveness lowered by hair loss and therefore produce male offspring who are prone to both high intellect and hair loss. However, by way of better socioeconomic standing and in turn more access to hair loss treatments, an association between intelligence and actual hair loss is less likely in recent times. Total testosterone exhibits a positive relation to tactual-spatial abilities and to the degree of lateralization. Total testosterone is negatively correlated with verbal fluency. Testosterone in the saliva is also significantly positively correlated to tactual-spatial test scores and, in addition, to field independence. DHT and the ratio DHT/total testosterone are positively related to verbal fluency and negatively to the degree of lateralization of tactual-spatial performance.[126]

Emotional stress has been shown to accelerate baldness in genetically susceptible individuals.[127] Stress due to sleep deprivation in military recruits lowered testosterone levels, but is not noted to have affected SHBG.[128] Thus, stress due to sleep deprivation in fit males is unlikely to elevate DHT, which causes male pattern baldness. Whether it can cause hair loss by some other mechanism is not clear.

Levels of free testosterone are strongly linked to libido and also DHT levels, but unless free testosterone is virtually nonexistent, levels have not been shown to affect virility. Men with androgenic alopecia are more likely to have a higher baseline of free androgens. However, sexual activity is multifactoral, and androgenic profile is also not the only determining factor in baldness. Additionally, because hair loss is progressive and free testosterone declines with age, a male's hairline may be more indicative of his past than his present disposition.[129][130]

There are many misconceptions about what can help prevent hair loss, one of these being that lack of sexual activity will automatically prevent hair loss. While a proven direct correlation exists between increased frequency of ejaculation and increased levels of DHT, as shown in a recent study by Harvard Medical School, the study suggests that ejaculation frequency may be a sign, rather than necessarily a cause, of higher DHT levels.[131] Moreover, MBP is genetically determined and theoretically occurs even with low levels of DHT. Another study shows that although sexual arousal and masturbation-induced orgasm increase testosterone concentration around orgasm, they reduce testosterone concentration on average (especially before abstinence) and because about 5% of testosterone is converted to DHT, ejaculation does not elevate DHT levels.[132]

The only published study to test correlation between ejaculation frequency and baldness was probably large enough to detect an association (1390 subjects) and found no correlation, although persons with only vertex androgenetic alopecia had had fewer female sexual partners than those of other androgenetic alopecia categories (such as frontal or both frontal and vertex). One study may not be enough especially in baldness, where there is a complex with age.[133] Marital status has been shown in some but not all studies to influence hair loss in cross-sectional studies (NHANES1).

While this may be a myth, increased circulation to the scalp can help provide hair follicles with needed nourishment to grow strong healthy hair.

While this may be a myth, hats do cause hair breakage and, to a lesser degree, split ends. Since hats are not washed as frequently as other clothing, they can also lead to scalp uncleanliness and possible Pityrosporum ovale contamination in men with naturally oily scalps. Some scalp infections, if left untreated, can cause hair loss.

See also

References

External links

  • NLM- Genetics Home Reference
  • PubMed)
    Citation will be completed automatically in a few minutes.

Jump the queue or expand by hand

  • expand by hand
  • How Hair Replacement Works Covers oral medications, hair transplant surgery, and topical treatments.
  • Male Pattern Baldness Genetics
  • USA Today
nl:Alopecia androgenetica
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.